Wednesday, September 25, 2020

Genelux Announces Closing of a Strategic Financing Transaction…more

Wednesday, September 16, 2020

Genelux to Present Data from Phase 2 Trial of Olvi-Vec in Heavily Pre-treated Platinum-Resistant/Refractory Ovarian Cancer at ESMO Virtual Congress 2020…more

Thursday, September 10, 2020

Genelux Announces Oral Plenary Presentation of VIRO-15 Phase 2 Trial Data at the 2020 xDigital Annual Global Meeting of the International Gynecologic Cancer Society…more

Thursday, June 04, 2020

Genelux Announces Formation of Clinical Advisory Board on Gynecologic Cancers… more

Thursday, May 07, 2020

Genelux Corporation Announces Productive Type C Meeting with FDA… more